PARK HOUSE — All Prescriptions & Medications — Page 3
Practice Code: M86044 | COVENTRY, CV1 2DL
Showing results 101-150 of 391
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Aripiprazole | 135 | 2,177 | £284 | -46.9% ▼ |
| Mometasone furoate | 133 | 135 | £1.1K | -66.9% ▼ |
| Desogestrel | 131 | 11.3K | £386 | -67.0% ▼ |
| Tirzepatide | 130 | 134 | £13.1K | -33.1% ▼ |
| Nifedipine | 123 | 4,508 | £1.0K | -34.4% ▼ |
| Calcipotriol | 123 | 9,300 | £5.6K | -27.7% ▼ |
| Levetiracetam | 117 | 9,696 | £427 | -74.4% ▼ |
| Pizotifen malate | 116 | 2,611 | £117 | +40.7% ▲ |
| Clobetasone butyrate | 116 | 7,805 | £823 | -43.2% ▼ |
| Olanzapine | 113 | 3,920 | £460 | -69.5% ▼ |
| Sodium valproate | 113 | 23.0K | £1.2K | -64.5% ▼ |
| Estradiol with progestogen | 113 | 4,964 | £2.9K | -66.8% ▼ |
| Dexamethasone | 113 | 570 | £356 | -34.3% ▼ |
| Codeine phosphate | 111 | 7,906 | £276 | -84.6% ▼ |
| Methotrexate | 109 | 2,268 | £448 | -66.5% ▼ |
| Digoxin | 108 | 3,024 | £217 | -71.5% ▼ |
| Carmellose sodium | 108 | 6,120 | £769 | +66.7% ▲ |
| Quinine sulfate | 106 | 2,968 | £408 | -63.4% ▼ |
| Letrozole | 105 | 2,940 | £267 | -43.8% ▼ |
| Canagliflozin | 104 | 3,150 | £3.9K | -27.6% ▼ |
| Oxybutynin | 101 | 6,020 | £145 | -47.0% ▼ |
| Diltiazem hydrochloride | 100 | 3,612 | £683 | -67.4% ▼ |
| Heparinoid | 100 | 12.5K | £684 | +281.3% ▲ |
| Carbamazepine | 98 | 4,200 | £287 | -67.0% ▼ |
| Esomeprazole | 96 | 4,397 | £336 | -76.3% ▼ |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 94 | 94 | £4.1K | -43.8% ▼ |
| Hydrocortisone acetate | 94 | 4,050 | £774 | +42.4% ▲ |
| Clarithromycin | 93 | 2,544 | £450 | -62.1% ▼ |
| Clobetasol propionate | 92 | 7,705 | £615 | -32.6% ▼ |
| 92 | 56.4K | £643 | -65.1% ▼ | |
| Mometasone furoate | 87 | 7,310 | £696 | -34.9% ▼ |
| Sacubitril/valsartan | 86 | 4,816 | £7.9K | -64.1% ▼ |
| Loratadine | 85 | 3,288 | £78 | -59.3% ▼ |
| Carbomer 940/980 | 85 | 950 | £181 | -44.2% ▼ |
| 85 | 89 | £97 | -61.4% ▼ | |
| Bimatoprost | 84 | 2,078 | £1.0K | -43.5% ▼ |
| Mirabegron | 83 | 2,420 | £2.2K | -79.3% ▼ |
| Hyoscine butylbromide | 81 | 4,623 | £322 | -65.2% ▼ |
| Biphasic insulin aspart | 81 | 549 | £3.3K | -20.2% ▼ |
| 79 | 735 | £216 | -62.2% ▼ | |
| Formoterol/glycopyrronium/budesonide | 78 | 78 | £3.3K | +29.5% ▲ |
| Lorazepam | 78 | 2,276 | £380 | -45.3% ▼ |
| Spironolactone | 76 | 2,254 | £306 | -85.9% ▼ |
| Melatonin | 76 | 2,856 | £2.2K | -77.1% ▼ |
| Semaglutide | 76 | 1,561 | £6.3K | -68.4% ▼ |
| Progesterone | 76 | 4,716 | £970 | -81.8% ▼ |
| Ferrous sulfate | 76 | 3,280 | £105 | -85.2% ▼ |
| Risperidone | 75 | 2,722 | £89 | -70.4% ▼ |
| Insulin degludec | 75 | 385 | £4.6K | -31.8% ▼ |
| Timolol | 75 | 1,285 | £338 | -15.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.